- Report
- June 2024
- 200 Pages
Global
From €7235EUR$7,950USD£6,203GBP
- Report
- January 2022
- 60 Pages
Global
From €3595EUR$3,950USD£3,082GBP
- Drug Pipelines
- April 2024
- 60 Pages
Global
From €1820EUR$2,000USD£1,560GBP
Pelvic Organ Prolapse (POP) is a condition in which the pelvic organs, such as the bladder, uterus, and rectum, drop from their normal position and press against the walls of the vagina. It is a common condition among women, especially those who have had multiple pregnancies or have gone through menopause. Treatment for POP includes lifestyle changes, physical therapy, and medications. Sexual and Reproductive Health Drugs are used to treat POP and other conditions related to sexual and reproductive health. These drugs can help reduce symptoms, improve quality of life, and prevent further damage to the pelvic organs.
Some companies in the Pelvic Organ Prolapse Drug market include Allergan, Pfizer, Merck, and Bayer. Show Less Read more